DVA
DaVita HealthCare Partners Inc
NYSE: DVA · HEALTHCARE · MEDICAL CARE FACILITIES
$240.96
+0.63% today
Updated 2026-07-29
Market cap
$15.21B
P/E ratio
22.83
P/S ratio
1.10x
EPS (TTM)
$10.38
Dividend yield
—
52W range
$101 – $240
Volume
0.8M
DaVita HealthCare Partners Inc (DVA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$240.96
12-Month target
$153.33
2030 Target
—
Intrinsic (DCF)
$124.67
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $11.6B | $12.1B | $12.8B | $13.6B | $14.1B | $14.6B | $15.1B | $15.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 3.39% (capped 20%) · P/E: 22.83x (capped 25x) · Margin: 5.65%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.